PADI4 and glioblastoma: These data demonstrate the involvement of PAD enzyme activity, and thus protein citrullination, in the modulation of GBM cell communication, signaling, and chemoresistance, suggesting that treatment of GBM with PAD inhibitors against specific targets represents a potential therapeutic strategy.